Atrial Fibrillation Market Was Valued at USD 1,945.6 million in 2021 Owing to Increased Prevalence of Heart Attacks and High Blood Pressure

According to Precision Business Insights (PBI) latest report the global atrial fibrillation market is valued at USD 1,945.6 million in 2021. Global atrial fibrillation market segmented into following types: By Type (Surgical, and Non-Surgical), By Technology (Radiofrequency, Laser, Cryotherapy, and Others), By End user (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East Africa) Forecast to 2028. Key player's profiles in the atrial fibrillation market report are Johnson & Johnson Private Limited., Boston Scientific Corporation, Medtronic, CardioFocus, Abbott, and Koninklijke Philips N.V. The atrial fibrillation market is fueled by the increased frequency of atrial fibrillation in elderly patients. Moreover, technological advancements also boost the atrial fibrillation market. Global atrial fibrillation market expansion is projected to be hampered by tight product approval rules.

Hospital Segment Dominates the Atrial Fibrillation Market:
The hospital segment generated the most income in 2021, owing to an increase in the usage of laser and radiofrequency ablation methods for catheter ablation. Moreover, increasing patient pool and increased technological advancements boost the growth of the segment.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-atrial-fibrillation-market/

North America Leads Atrial Fibrillation Market:
Because of the growing patient pool, technological improvements, and the availability of favorable insurance plans, North America atrial fibrillation is expected to have a considerable market share in the global market in the next years. Furthermore, an increasing number of patients with atrial fibrillation in European countries, appropriate rules enabling increased catheter use, and surgical ablation therapies for atrial fibrillation are all drivers driving the European atrial fibrillation surgery market.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global atrial fibrillation market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In June 2021, CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced that it has entered into a licensing and distribution agreement with China Grand Pharmaceutical (Grand Pharma). The agreement provides a license to Grand Pharma to seek regulatory approvals and commercialize the HeartLight X3 System in China, Hong Kong and Macau. The HeartLight X3 System is CardioFocus' catheter ablation technology for controlled and consistent pulmonary vein isolation (PVI), the gold standard treatment for atrial fibrillation.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=25131

Detailed Segmentation:
The atrial fibrillation market is segmented based on type, technology, end-user, and geography.
Based on the Type, the market is segmented into the following:
• Surgical
• Non-Surgical

Based on the Technology, the market is segmented into the following:
• Radiofrequency
• Laser
• Cryotherapy
• Others

Based on the End-user, the market is segmented into the following:
• Hospitals
• Specialty Clinics
• Others

Based on the geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.